Choice of Modality of Follow up for Medication Abortion

Not Recruiting

Trial ID: NCT04056637


This study will assess the impact of providing medication abortion-seeking clients a choice for follow-up in practice. Clients presenting at or less than 63 days pregnant (based on last menstrual period) at the study site for first trimester medication abortion will be invited to participate. We hypothesize that providing clients with flexible follow-up options will improve follow-up rates. This study is not to assess efficacy or safety of follow-up methods--that has been well established in practice and research. This is to assess choice of follow-up.

Official Title

Choice of Modality of Follow up for Medication Abortion

Stanford Investigator(s)

Paul D. Blumenthal, MD, MPH
Paul D. Blumenthal, MD, MPH

Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus


Inclusion Criteria:

   - Eligible for medication abortion <63 days gestational age

   - In general good health

   - English or Spanish speaking competency

   - Willing and able to sign consent forms

Exclusion Criteria:

   - Clients less than 18 years of age.

   - Any client not meeting the inclusion criteria listed above will be excluded from
   participating in the trial.


other: Choice of follow-up option

device: Multi-level pregnancy test

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Research Manager, MPH